Cinnamaldehyde protects from the hypertension associated with diabetes

Food and Chemical Toxicology

Volumn 49, Issue 11, 2011, Pages 3007-3012

  El Bassossy, Hany M ^a,b   Fahmy, Ahmed ^a   Badawy, Dina ^a  

^a Zagazig University   (Egypt)

^b WAKE FOREST UNIVERSITY   (United States)

Author keywords

Aorta; Cinnamaldehyde; Contraction; Diabetes; Hypertension; Relaxation

Indexed keywords

ACETYLCHOLINE; CALCIUM ION; CINNAMALDEHYDE; FRUCTOSE; GLICLAZIDE; GLUCOSE; INSULIN; NITRIC OXIDE; PHENYLEPHRINE; PIOGLITAZONE; POTASSIUM CHLORIDE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; CALCIUM TRANSPORT; CONTROLLED STUDY; DIABETIC HYPERTENSION; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN LIKE ACTIVITY; INSULIN RESISTANCE; MALE; NONHUMAN; PROTECTION; RAT; SMOOTH MUSCLE CONTRACTILITY; STREPTOZOCIN DIABETES; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ACETYLCHOLINESTERASE; ACROLEIN; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; CALCIUM; DIABETES MELLITUS, EXPERIMENTAL; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; NITRIC OXIDE; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; THIAZOLIDINEDIONES; VASOCONSTRICTION;

RATTUS;

EID: 80053562178     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.07.060     Document Type: Article

References (32)

1. Akbari C.M., LoGerfo F.W. Diabetes and peripheral vascular disease. J Vasc. Surg. 1999, 30:373-384.
2. Altan V.M. The pharmacology of diabetic complications. Curr. Med. Chem. 2003, 10:1317-1327.
3. Anand P., Murali K.Y., Tandon V., Murthy P.S., Chandra R. Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats. Chem. Biol. Interact. 2010, 186:72-81.
4. Baluchnejadmojarad T., Roghani M., Homayounfar H., Hosseini M. Beneficial effect of aqueous garlic extract on the vascular reactivity of streptozotocin-diabetic rats. J. Ethnopharmacol. 2003, 85:139-144.
5. Barham D., Trinder P. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 1972, 97:142-145.
6. Busija D.W., Miller A.W., Katakam P., Erdos B. Adverse effects of reactive oxygen species on vascular reactivity in insulin resistance. Antioxid. Redox Signal 2006, 8:1131-1140.
7. Carmassi F., De Negri F., Fioriti R., De Giorgi A., Giannarelli C., Fruzzetti F., Pedrinelli R., Dell'Omo G., Bersi C. Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome. Thromb. Res. 2005, 116:207-214.
8. Chang S.T., Chen P.F., Chang S.C. Antibacterial activity of leaf essential oils and their constituents from Cinnamomum osmophloeum. J. Ethnopharmacol. 2001, 77:123-127.
9. Chao L.K., Hua K.F., Hsu H.Y., Cheng S.S., Lin I.F., Chen C.J., Chen S.T., Chang S.T. Cinnamaldehyde inhibits pro-inflammatory cytokines secretion from monocytes/macrophages through suppression of intracellular signaling. Food Chem. Toxicol. 2008, 46:220-231.
10. Cheng S.S., Liu J.Y., Tsai K.H., Chen W.J., Chang S.T. Chemical composition and mosquito larvicidal activity of essential oils from leaves of different cinnamomum osmophloeum provenances. J. Agric. Food Chem. 2004, 52:4395-4400.
11. Dai S., McNeill J.H. Fructose-induced hypertension in rats is concentration- and duration-dependent. J. Pharmacol. Toxicol. Methods 1995, 33:101-107.
12. Donnelly R., Qu X. Mechanisms of insulin resistance and new pharmacological approaches to metabolism and diabetic complications. Clin. Exp. Pharmacol. Physiol. 1998, 25:79-87.
13. El-Bassossy H.M., El-Maraghy N.N., El-Fayoumi H.M., Watson M.L. Haem oxygenase-1 induction protects against tumour necrosis factor alpha impairment of endothelial-dependent relaxation in rat isolated pulmonary artery. Br. J. Pharmacol. 2009, 158:1527-1535.
14. El-Bassossy, H.M., El-Moselhy, M.A., Mahmoud, M.F., in press. Pentoxifylline alleviates vascular impairment in insulin resistance via inhibition of TNFα. N-S Arch Pharmacol.
15. El-Ghoneimi A., Cursio R., Schmid-Alliana A., Tovey M., Lasfar A., Michiels J.F., Rossi B., Gugenheim J. Pentoxifylline inhibits liver expression of tumor necrosis factor alpha mRNA following normothermic ischemia-reperfusion. HPB (Oxford) 2007, 9:112-119.
16. Hu N., Xie S., Liu L., Wang X., Pan X., Chen G., Zhang L., Liu H., Liu X., Liu X., Xie L., Wang G. Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats. Drug Metab. Dispos. 2011, 39:419-425.
17. Iyer S.N., Katovich M.J. Vascular reactivity to phenylephrine and angiotensin II in hypertensive rats associated with insulin resistance. Clin. Exp. Hypertens. 1996, 18:227-242.
18. Kinoshita Y., Saito M., Satoh I., Shomori K., Suzuki H., Yamada M., Kono T., Satoh K. General administration of cyclohexenonic long-chain fatty alcohol ameliorates hyperreactivity of STZ-induced diabetic rat aorta. Life Sci. 2006, 78:1508-1514.
19. Lee H.S. Inhibitory activity of Cinnamomum cassia bark-derived component against rat lens aldose reductase. J. Pharm. Pharm. Sci. 2002, 5:226-230.
20. Mahmoud, M.F., El-Moselhy, M.A., El-Bassossy, H.M., in press. Atorvastatin improves vascular reactivity and reduces inflammation associated with insulin resistance in fructose fed rats. Arch Pharmacal Res.
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
22. Morgan J.P., Morgan K.G. Calcium and cardiovascular function. Intracellular calcium levels during contraction and relaxation of mammalian cardiac and vascular smooth muscle as detected with aequorin. Am. J. Med. 1984, 77:33-46.
23. Oliveira-Junior I.S., de O., Maganhin C.C., Carbonel A.A., Monteiro C.M., Cavassani S.S., Oliveira-Filho R.M. Effects of pentoxifylline on TNF-alpha and lung histopathology in HCL-induced lung injury. Clinics (Sao Paulo) 2008, 63:77-84.
24. Shinozaki K., Ayajiki K., Nishio Y., Sugaya T., Kashiwagi A., Okamura T. Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 2004, 43:255-262.
25. Somlyo A.P., Somlyo A.V. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J. Physiol. 2000, 522:177-185.
26. Subash Babu P., Prabuseenivasan S., Ignacimuthu S. Cinnamaldehyde - A potential antidiabetic agent. Phytomedicine 2007, 14:15-22.
27. Sui F., Lin N., Guo J.Y., Zhang C.B., Du X.L., Zhao B.S., Liu H.B., Yang N., Li L.F., Guo S.Y., Huo H.R., Jiang T.L. Cinnamaldehyde up-regulates the mRNA expression level of TRPV1 receptor potential ion channel protein and its function in primary rat DRG neurons in vitro. J. Asian Nat. Prod. Res. 2010, 12:76-87.
28. Takagawa Y., Berger M.E., Hori M.T., Tuck M.L., Golub M.S. Long-term fructose feeding impairs vascular relaxation in rat mesenteric arteries. Am. J. Hypertens. 2001, 14:811-817.
29. Xavier F.E., Davel A.P., Rossoni L.V., Vassallo D.V. Time-dependent hyperreactivity to phenylephrine in aorta from untreated diabetic rats: role of prostanoids and calcium mobilization. Vasc. Pharmacol. 2003, 40:67-76.
30. Xue Y.L., Shi H.X., Murad F., Bian K. Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta. Vasc. Health Risk Manag. 2011, 7:273-280.
31. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol. Rev. 1998, 50:21-34.
32. Zhang W., Xu Y.C., Guo F.J., Meng Y., Li M.L. Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. Chin. Med. J. (Engl). 2008, 121:2124-2128.